These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8887602)

  • 1. Lack of association of induration size with HIV infection among drug users reacting to tuberculin.
    Gourevitch MN; Hartel D; Schoenbaum EE; Klein RS
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1029-33. PubMed ID: 8887602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ; Aldamiz-Etxebarria M; Agud JM; Arévalo JM; Almaraz MJ; Ayensa C
    Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of induration size with HIV infection among drug users reacting to tuberculin.
    Daniel TM
    Am J Respir Crit Care Med; 1997 May; 155(5):1816-7. PubMed ID: 9154898
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
    Diagbouga S; Fumoux F; Ledru E; Sanou PT; Barro D; Marchal G
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):317-23. PubMed ID: 9559403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).
    Anastos K; Kalish LA; Palacio H; Benson CA; Delapenha R; Chirgwin K; Stonis L; Telzak EE
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):141-7. PubMed ID: 10360806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV seropositive and seronegative patients.
    Ratanasuwan W; Kreiss JK; Nolan CM; Schaeffler BA; Suwanagool S; Tunsupasawasdikul S; Chuchottaworn C; Dejsomritrutai W; Foy HM
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):259-64. PubMed ID: 9432374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
    Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
    N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients. The Gruppo Italiano di Studio Tubercolosi e AIDS.
    Girardi E; Antonucci G; Ippolito G; Raviglione MC; Rapiti E; Di Perri G; Babudieri S
    Arch Intern Med; 1997 Apr; 157(7):797-800. PubMed ID: 9125013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
    Klein RS; Gourevitch MN; Teeter R; Schoenbaum EE
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):707-11. PubMed ID: 11495260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
    Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
    Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of positive tuberculin reactions in women with or at risk for HIV-1 infection. HER Study Group. HIV Epidemiology Research.
    Klein RS; Smith D; Sobel J; Flanigan T; Margolick JB
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):688-92. PubMed ID: 10907773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.
    Kimura M; Converse PJ; Astemborski J; Rothel JS; Vlahov D; Comstock GW; Graham NM; Chaisson RE; Bishai WR
    J Infect Dis; 1999 May; 179(5):1297-300. PubMed ID: 10191241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.